REDX PHARMA PLC

M2 3AW (North West)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£515,579

Oct 19 - Jan 21

Pre-Clinical Validation and Translation of a Novel Anti-Fibrotic

Innovate UK award to REDX PHARMA PLC and Peter Bunyard

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}